- Home
- IVVD vs FRA Comparison
IVVD vs FRA Comparison
Compare IVVD & FRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVVD
- FRA
- Stock Information
- Founded
- IVVD 2020
- FRA 2003
- Country
- IVVD United States
- FRA United States
- Employees
- IVVD N/A
- FRA N/A
- Industry
- IVVD Biotechnology: Pharmaceutical Preparations
- FRA Investment Bankers/Brokers/Service
- Sector
- IVVD Health Care
- FRA Finance
- Exchange
- IVVD Nasdaq
- FRA Nasdaq
- Market Cap
- IVVD 412.6M
- FRA 437.8M
- IPO Year
- IVVD 2021
- FRA N/A
- Fundamental
- Price
- IVVD $2.57
- FRA $11.70
- Analyst Decision
- IVVD Strong Buy
- FRA
- Analyst Count
- IVVD 5
- FRA 0
- Target Price
- IVVD $6.11
- FRA N/A
- AVG Volume (30 Days)
- IVVD 11.9M
- FRA 165.4K
- Earning Date
- IVVD 11-06-2025
- FRA 01-01-0001
- Dividend Yield
- IVVD N/A
- FRA 11.06%
- EPS Growth
- IVVD N/A
- FRA N/A
- EPS
- IVVD N/A
- FRA N/A
- Revenue
- IVVD $50,039,000.00
- FRA N/A
- Revenue This Year
- IVVD $102.11
- FRA N/A
- Revenue Next Year
- IVVD $151.51
- FRA N/A
- P/E Ratio
- IVVD N/A
- FRA N/A
- Revenue Growth
- IVVD 332.71
- FRA N/A
- 52 Week Low
- IVVD $0.35
- FRA $11.33
- 52 Week High
- IVVD $3.07
- FRA $13.10
- Technical
- Relative Strength Index (RSI)
- IVVD 64.50
- FRA 14.43
- Support Level
- IVVD $2.38
- FRA $12.32
- Resistance Level
- IVVD $2.70
- FRA $12.13
- Average True Range (ATR)
- IVVD 0.25
- FRA 0.13
- MACD
- IVVD 0.07
- FRA -0.05
- Stochastic Oscillator
- IVVD 69.01
- FRA 5.04
About IVVD Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
About FRA Blackrock Floating Rate Income Strategies Fund Inc
Blackrock Floating Rate Inc Stra Fd Inc is a United States-based diversified closed-ended management investment company. The Fund's investment objective is to provide shareholders with high current income and preservation of capital with investment in a diversified, leveraged portfolio consisting of floating-rate debt securities and instruments.